» Articles » PMID: 35898811

Trends and Predictors of Specialist Assessments in Oral Corticosteroid Treated Asthma Among Young Adults

Overview
Journal ERJ Open Res
Specialty Pulmonary Medicine
Date 2022 Jul 28
PMID 35898811
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Repeated oral corticosteroid use indicates uncontrolled disease among asthma patients, and referral for asthma specialist assessment is recommended. We aimed to describe trends and predictors associated with specialist contacts among young adults with asthma and repeated oral corticosteroid use.

Methods: Individuals aged 18-45 years with two or more dispensed asthma medication prescriptions and two dispended oral corticosteroid prescriptions (including short-term and long-term treatments) within 12 months during 1999-2018 were identified by use of Danish healthcare registers. The frequency of specialist contacts within 1 year of follow-up was assessed among individuals without previous specialist contacts within 5 years of inclusion. Factors associated with specialist contact were identified using logistic regression models. Furthermore, oral corticosteroid prescriber sources were assessed.

Results: For the 11 223 individuals included, 2444 (22%) had previous specialist-contact care within 5 years prior of inclusion, and additionally 926 (8.3%) within 1 year of follow-up. Among those without previous specialist contacts (n=8779), the frequency of incident specialist contacts within 1 year of follow-up increased from 6.3% in 1999 to 18% in 2017. Factors associated with incident specialist contacts included dispensing ≥12 short-acting β-agonist canisters and previous asthma-related emergency department visits and hospitalisations. The majority of oral corticosteroid prescriptions at baseline (71%) were prescribed by general practitioners, although with decreasing proportions from 1999 to 2018.

Conclusions: The majority (70%) of young adults with asthma and repeated oral corticosteroid use do not seem to receive specialist assessment in Denmark. This highlights a potential room for improvement in the patient referral pathway for at-risk asthma patients.

References
1.
Hvidberg M, Johnsen S, Davidsen M, Ehlers L . A Nationwide Study of Prevalence Rates and Characteristics of 199 Chronic Conditions in Denmark. Pharmacoecon Open. 2019; 4(2):361-380. PMC: 7248158. DOI: 10.1007/s41669-019-0167-7. View

2.
Price D, Bjermer L, Bergin D, Martinez R . Asthma referrals: a key component of asthma management that needs to be addressed. J Asthma Allergy. 2017; 10:209-223. PMC: 5536139. DOI: 10.2147/JAA.S134300. View

3.
Hakansson K, Backer V, Ulrik C . Socioeconomic biases in asthma control and specialist referral of possible severe asthma. Eur Respir J. 2021; 58(6). DOI: 10.1183/13993003.00741-2021. View

4.
Jensen A, Nielsen G, Ehrenstein V . Validity of asthma diagnoses in the Danish National Registry of Patients, including an assessment of impact of misclassification on risk estimates in an actual dataset. Clin Epidemiol. 2010; 2:67-72. PMC: 2943183. DOI: 10.2147/clep.s6875. View

5.
Hew M, McDonald V, Bardin P, Chung L, Farah C, Barnard A . Cumulative dispensing of high oral corticosteroid doses for treating asthma in Australia. Med J Aust. 2020; 213(7):316-320. PMC: 7589219. DOI: 10.5694/mja2.50758. View